Possible suppressor of Diabetes?

Roni Rabin writes in The New York Times about the new development of a drug called Pioglitazone, or Actos, a medical drug advertised to help with preventing diabetes or controlling diabetes. Rabin goes on to note that this drug is developed from the same company as the older diabetes drug Avandia. Avandia is completely banded from Europe and is only rarely used in America due to its various side effects

Pioglitazone is believed to be safer than rosiglitazone, but it has been linked to an increased risk of congestive heart failure, and the Food and Drug Administration is investigating a possible link to bladder cancer.

However, after a recent statistical study with this drug, it seems that those who take Actos do receive more benefits than those who did not take any diabetes preventative drug at all. The only observed negatives were that the patients gained weight and had a lot more water retention in their bladders than those who didn't take Actos. Certainly there has never been a drug that has been approved federally to prevent any sort of diabetes at all. However, it will take some time due to the fact that there are always negative side effects. Patients will just have to wait until a drug with minimal damage is developed.